Resistence-based Helicobacter pylori eradication and Antibiotic Stewardship
Recruiting
- Conditions
- B98.0Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
- Registration Number
- DRKS00033330
- Lead Sponsor
- St. Vincenz-Krankenhaus Datteln
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
All inpatients and outpatients with reason for gastroscopy.
Exclusion Criteria
Age < 18
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The aim of the study is resistance testing and adequate therapy at the beginning of the diagnosis of Helicobacter pylori to avoid treatment failure and requirement of new diagnostic biopsies. Additionally we want to get regional resistance data and save antibiotics to affect development of resistance positively.<br>We want to measure this aim with culturing of Helicobacter pylori in routinely taken gastric biopsies and sensitivity testing. The doctor of subsequent treatment will be informed to wait for sensitivity test results before starting the eradication therapy. Furthermore, we want to contact this doctor after 2-3 months again to get information about subscribed antiobiotics and therapeutic success.
- Secondary Outcome Measures
Name Time Method not applicable